Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review

Canadian Agency for Drugs and Technologies in Health
Record ID 32011001177
Authors' recomendations: In summary, despite addressing slightly different research questions and differences in the methodologies used in the two reports (the MUHC TAVI report was a systematic review while the CADTH report was a rapid review), the conclusions about the use of TAVI to treat patients with severe aortic stenosis who would not otherwise be surgical candidates for aortic valve replacement are similar. Both reports described the procedure as feasible and recognized the risks associated with undergoing the procedure and the potential for symptomatic relief. No information on cost-effectiveness was identified by either report. An update to the CADTH rapid review is currently underway and is due to be completed in May, 2010.
Project Status: Completed
Year Published: 2010
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Aortic Valve
  • Aortic Valve Stenosis
  • Review Literature as Topic
  • Technology Assessment, Biomedical
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.